Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.
Open Access
- 1 May 1996
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 183 (5), 2219-2226
- https://doi.org/10.1084/jem.183.5.2219
Abstract
Expression of the bcl-2 gene has been shown to effectively confer resistance to programmed cell death under a variety of circumstances. However, despite a wealth of literature describing this phenomenon, very little is known about the mechanism of resistance. In the experiments described here, we show that bcl-2 gene expression can result in an inhibition of cell division cycle progression. These findings are based upon the analysis of cell cycle distribution, cell cycle kinetics, and relative phosphorylation of the retinoblastoma tumor suppressor protein, using primary tissues in vitro, ex vivo, and in vitro, as well as continuous cell lines. The effects of bcl-2 expression on cell cycle progression appear to be focused at the G(1) to S phase transition, which is a critical control point in the decision between continued cell cycle progression or the induction programmed cell death. In all systems tested, bcl-2 expression resulted in a substantial 30-60% increase in the length of G(1) phase; such an increase is very substantial in the context of other regulators of cell cycle progression. Based upon our findings, and the related findings of others, we propose a mechanism by which bcl-2 expression might exert its well known inhibition of programmed cell, death by regulating the kinetics of cell cycle progression at a critical control point.Keywords
This publication has 27 references indexed in Scilit:
- T cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production.The Journal of Experimental Medicine, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Turnover of naive- and memory-phenotype T cells.The Journal of Experimental Medicine, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- The cell cycle and cell deathCurrent Biology, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985